Biotech Fades After ASCO Abstract Rally
May 26, 2017 at 19:29 PM EDT
Biotechs faded today now that the rush of oncology drug news cooled down. Today was dominated by the “red screen” with profit taking mainly in smaller caps and momentum driven oncology stocks.